跳至主要内容
临床试验/NCT07603778
NCT07603778已完成不适用

Using Voice Technology to Identify Opioid Use in Patients in Treatment for Opioid Use Disorder

Tenvos Inc.1 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2024年12月10日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
41
试验地点
1

研究概览

简要总结

This study explored whether changes in a person's voice could help identify opioid use in patients with opioid use disorder (OUD). Current methods for determining whether a patient is intoxicated or in withdrawal often rely on self-reporting and clinical judgment, which can be subjective and inconsistent. Drug tests are logistically challenging to administer and can be costly with repeated use.

The project investigated whether physiological changes associated with opioid use could be detected through speech analysis technology. Researchers evaluated whether machine learning methods could identify voice patterns associated with opioid intoxication or withdrawal.

The primary goal of the study was to assess the accuracy of voice-based biomarkers in identifying opioid use. The study also explored relationships between opioid use and specific speech characteristics.

详细描述

This study investigated whether changes in a person's voice could be used to identify opioid use in individuals with opioid use disorder (OUD). The opioid epidemic continues to present significant public health, medical, and social challenges in the United States and globally. Clinicians treating patients with OUD often need to determine whether a patient may be actively using opioids, intoxicated, withdrawing, or responding appropriately to treatment. Current approaches commonly rely on self-reporting, interviews, behavioral observations, urine toxicology testing, and clinical judgment. While these methods can be useful, they may also be subjective, resource-intensive, intermittent, invasive, or difficult to implement frequently in routine care settings.

The purpose of this project was to evaluate whether speech analysis technology could provide a more objective, scalable, and non-invasive approach for monitoring opioid-related physiological changes. Human speech is a complex neuromuscular activity that depends on the coordinated function of the brain, respiratory system, vocal tract, and facial musculature. Opioids can affect cognitive processing, respiratory patterns, motor coordination, reaction time, sedation levels, and muscle control, all of which may influence characteristics of speech production. Prior scientific literature has suggested that physiological and neurological conditions can sometimes produce measurable changes in speech patterns. This project sought to determine whether similar measurable changes could be associated with opioid use.

The study focused specifically on analyzing speech recordings from participants with opioid use disorder. Researchers collected voice samples and applied computational analysis methods to evaluate whether acoustic and temporal speech features could distinguish opioid-related states. The project used signal-processing techniques and machine learning methods to analyze a range of speech characteristics that may reflect physiological effects associated with opioid exposure.

Evaluated speech features included acoustic biomarkers commonly studied in speech analytics research. The project investigated whether combinations of these features could be used to identify patterns associated with opioid intoxication or withdrawal.

A major goal of the study was to assess the feasibility of using speech as a physiological biomarker for opioid use monitoring. Researchers evaluated whether machine learning models could reliably differentiate between opioid-related conditions using speech data alone.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female
  • At least 18 years old
  • Be an active patient in treatment at the Volpicelli Center
  • Have a diagnosis of Opioid Use Disorder (OUD)
  • Ability to read English
  • Able to comprehend and are willing to sign the informed consent form and are able to adhere to the protocol

排除标准

  • Severe psychiatric comorbidity
  • A chronic medical condition that interferes with speaking (note: Acute conditions that impair speech or hearing will not be considered exclusionary, but testing will be deferred until the temporary condition has been resolved)
  • Non-fluency in the study language (English)

研究者

发起方
Tenvos Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验